Cardiac steatosis and left ventricular hypertrophy in patients with generalized lipodystrophy as determined by magnetic resonance spectroscopy and imaging

American Journal of Cardiology

Volumn 112, Issue 7, 2013, Pages 1019-1024

  Nelson, Michael D ^a   Victor, Ronald G ^a   Szczepaniak, Edward W ^a   Simha, Vinaya ^c   Garg, Abhimanyu ^b   Szczepaniak, Lidia S ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; LIPODYSTROPHY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STEATOSIS;

ADIPOSE TISSUE; ADOLESCENT; ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; FEMALE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LIPODYSTROPHY, CONGENITAL GENERALIZED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MYOCARDIUM; ORGAN SIZE; PERICARDIUM; TRIGLYCERIDES; YOUNG ADULT;

EID: 84884418143     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.05.036     Document Type: Article

References (22)

1. A. Garg Lipodystrophies: genetic and acquired body fat disorders J Clin Endocrinol Metab 96 2011 3313 3325
2. L.S. Szczepaniak, E.E. Babcock, F. Schick, R.L. Dobbins, A. Garg, D.K. Burns, J.D. McGarry, and D.T. Stein Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo Am J Physiol Endocrinol Metab 276 1999 E977 E989
3. V. Simha, L.S. Szczepaniak, A.J. Wagner, A.M. DePaoli, and A. Garg Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy Diabetes Care 26 2003 30 35
4. A. Garg, and A. Misra Lipodystrophies: rare disorders causing metabolic syndrome Endocrinol Metab Clin of North Am 33 2004 305 331
5. B.C. Lupsa, V. Sachdev, A.O. Lungu, D.R. Rosing, and P. Gorden Cardiomyopathy in congenital and acquired generalized lipodystrophy: a clinical assessment Medicine 89 2010 245 250
6. D. DuBois, and E. DuBois A formula to estimate the approximate surface area if height and weight be known Arch Intern Med 17 1916 863 871
7. Z. Ahmad, L. Subramanyam, L. Szczepaniak, V. Simha, B. Adams-Huet, and A. Garg Cholic acid for hepatic steatosis in patients with lipodystrophy: a randomized, controlled trial Eur J Endocrinol 168 2013 771 778
8. J.M. McGavock, I. Lingvay, I. Zib, T. Tillery, N. Salas, R. Unger, B.D. Levine, P. Raskin, R.G. Victor, and L.S. Szczepaniak Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study Circulation 116 2007 1170 1175
9. M. Riley-Hagan, R.M. Peshock, J. Stray-Gundersen, J. Katz, T.W. Ryschon, and J.H. Mitchell Left ventricular dimensions and mass using magnetic resonance imaging in female endurance athletes Am J Cardiol 69 1992 1067 1074
10. L.S. Szczepaniak, R.L. Dobbins, D.T. Stein, and J.D. McGarry Bulk magnetic susceptibility effects on the assessment of intra- and extramyocellular lipids in vivo Magn Reson Med 47 2002 607 610
11. L.S. Szczepaniak, P. Nurenberg, D. Leonard, J.D. Browning, J.S. Reingold, S. Grundy, H.H. Hobbs, and R.L. Dobbins Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population Am J Physiol Endocrinol Metab 288 2005 E462 E468
12. Y. Lee, M.Y. Wang, T. Kakuma, Z.W. Wang, E. Babcock, K. McCorkle, M. Higa, Y.T. Zhou, and R.H. Unger Liporegulation in diet-induced obesity: the antisteatotic role of hyperleptinemia J Biol Chem 276 2001 5629 5635
13. B.N. Finck, and D.P. Kelly Peroxisome proliferator-activated Receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart J Mol Cell Cardiol 34 2002 1249 1257
14. B.N. Finck, J.J. Lehman, T.C. Leone, M.J. Welch, M.J. Bennett, A. Kovacs, X. Han, R.W. Gross, R. Kozak, G.D. Lopaschuk, and D.P. Kelly The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus J Clin Invest 109 2002 121 130
15. R.A. Arky, and K.S. McCully Case 1-1975 N Engl J Med 292 1975 35 41
16. M. Chandalia, A. Garg, F. Vuitch, and F. Nizzi Postmortem findings in congenital generalized lipodystrophy J Clin Endocrinol Metab 80 1995 3077 3081
17. A. Garg, J.L. Fleckenstein, R.M. Peshock, and S.M. Grundy Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy J Clin Endocrinol Metab 75 1992 358 361
18. D. Corradi, R. Maestri, S. Callegari, P. Pastori, M. Goldoni, T.V. Luong, and C. Bordi The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts Cardiovasc Pathol 13 2004 313 316
19. G. Iacobellis, M.C. Ribaudo, A. Zappaterreno, C.V. Iannucci, and F. Leonetti Relation between epicardial adipose tissue and left ventricular mass Am J Cardiol 94 2004 1084 1087
20. G. Iacobellis, N. Singh, S. Wharton, and A.M. Sharma Substantial changes in epicardial fat thickness after weight loss in severely obese subjects Obesity 16 2008 1693 1697
21. H.C. Chiu, A. Kovacs, D.A. Ford, F.F. Hsu, R. Garcia, P. Herrero, J.E. Saffitz, and J.E. Schaffer A novel mouse model of lipotoxic cardiomyopathy J Clin Invest 107 2001 813 822
22. D.J. Glenn, F. Wang, M. Nishimoto, M.C. Cruz, Y. Uchida, W.M. Holleran, Y. Zhang, Y. Yeghiazarians, and D.G. Gardner A murine model of isolated cardiac steatosis leads to cardiomyopathy Hypertension 57 2011 216 222